company background image

Orphazyme CPSE:ORPHA Stock Report

Last Price


Market Cap







02 Oct, 2023


Company Financials

ORPHA Stock Overview

Orphazyme A/S does not have significant operations.

ORPHA fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health6/6

Orphazyme A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orphazyme
Historical stock prices
Current Share Pricekr.1.00
52 Week Highkr.5.37
52 Week Lowkr.0.68
1 Month Change-12.54%
3 Month Change-37.33%
1 Year Change-22.47%
3 Year Change-98.56%
5 Year Change-98.44%
Change since IPO-98.75%

Recent News & Updates

Recent updates

What Type Of Shareholders Make Up Orphazyme A/S' (CPH:ORPHA) Share Registry?

Mar 04
What Type Of Shareholders Make Up Orphazyme A/S' (CPH:ORPHA) Share Registry?

How Many Orphazyme A/S (CPH:ORPHA) Shares Do Institutions Own?

Nov 19
How Many Orphazyme A/S (CPH:ORPHA) Shares Do Institutions Own?

Shareholder Returns

ORPHADK BiotechsDK Market

Return vs Industry: ORPHA underperformed the Danish Biotechs industry which returned 3.1% over the past year.

Return vs Market: ORPHA underperformed the Danish Market which returned 32.7% over the past year.

Price Volatility

Is ORPHA's price volatile compared to industry and market?
ORPHA volatility
ORPHA Average Weekly Movement12.5%
Biotechs Industry Average Movement7.0%
Market Average Movement4.0%
10% most volatile stocks in DK Market9.4%
10% least volatile stocks in DK Market2.5%

Stable Share Price: ORPHA is more volatile than 90% of Danish stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: ORPHA's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

20091Anders Vadsholt

Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Orphazyme A/S Fundamentals Summary

How do Orphazyme's earnings and revenue compare to its market cap?
ORPHA fundamental statistics
Market Capkr.35.45m
Earnings (TTM)-kr.26.65m
Revenue (TTM)n/a


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ORPHA income statement (TTM)
Cost of Revenuekr.0
Gross Profitkr.0
Other Expenseskr.26.65m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date


Earnings per share (EPS)-0.75
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did ORPHA perform over the long term?

See historical performance and comparison